NCT01751802View on ClinicalTrials.gov

Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions
Lesch-Nyhan DiseaseSelf-injurious Behavior
Interventions
DRUG

Ecopipam

Antagonist of the dopamine D1 receptor

DRUG

Placebo

Placebo for Ecopipam

Trial Locations (2)

30322

H.J. Jinnah, Atlanta

Unknown

Hospital Universitario La Paz, Madrid

Sponsors
All Listed Sponsors
collaborator

Psyadon Pharma

INDUSTRY

lead

Emalex Biosciences Inc.

INDUSTRY